← Eichor
Study identifier: NCT04743141 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Condition: Acute Treatment of Migraine  ·  Sponsor: Pfizer

PhasePhase 3
Planned participants600
Who can joinAll sexes, 6 Years to 17 Years
Healthy volunteersNo

About this study

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).

This description comes directly from the study's public registry record.

Talk to the study team

Pfizer Pfizer CT.gov Call Center  ·  1-800-718-1021  ·  ClinicalTrials.gov_Inquiries@pfizer.com

Always discuss trial participation with your own doctor first.

Locations (125)

Perseverance Research Center, LLCScottsdale, Arizona, United StatesRecruiting
Physicians Research GroupTempe, Arizona, United StatesActive Not Recruiting
Advanced Research Center, Inc.Anaheim, California, United StatesRecruiting
ProScience Research GroupCulver City, California, United StatesActive Not Recruiting
Neuro-Pain Research CenterFresno, California, United StatesRecruiting
Altman Clinical and Translational Research Institute, University of California San DiegoLa Jolla, California, United StatesRecruiting
Adult & Child Neurology Medical AssociatesLong Beach, California, United StatesRecruiting
Memorialcare Miller Children's & Women's Hospital Long BeachLong Beach, California, United StatesRecruiting
Velocity Clinical Research - North HollywoodNorth Hollywood, California, United StatesActive Not Recruiting
The Neurology GroupPomona, California, United StatesRecruiting
UC Davis Medical Center, Investigational Drug Service (IDS) PharmacySacramento, California, United StatesActive Not Recruiting
University of California, Davis Clinical and Translational Science Center Clinical Research CenterSacramento, California, United StatesActive Not Recruiting

+ 113 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04743141